# Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System

> **NCT00094536** · PHASE4 · COMPLETED · sponsor: **CooperSurgical Inc.** · enrollment: 82 (actual)

## Conditions studied

- Menorrhagia

## Interventions

- **DEVICE:** Extended treatment regimen using Her Option Cryotherapy

## Key facts

- **NCT ID:** NCT00094536
- **Lead sponsor:** CooperSurgical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2007-10
- **Final completion:** 2009-06
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00094536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00094536, "Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00094536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*